EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 208 filers reported holding EXELIXIS INC in Q3 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $724,000 | +120.7% | 33,630 | +126.8% | 0.22% | +103.7% |
| Q1 2018 | $328,000 | -27.3% | 14,830 | 0.0% | 0.11% | -26.4% |
| Q4 2017 | $451,000 | +25.6% | 14,830 | 0.0% | 0.15% | +24.4% |
| Q3 2017 | $359,000 | -43.3% | 14,830 | -42.3% | 0.12% | -34.3% |
| Q2 2017 | $633,000 | +35.8% | 25,700 | -17.8% | 0.18% | +70.8% |
| Q4 2016 | $466,000 | +16.5% | 31,270 | 0.0% | 0.11% | +11.6% |
| Q3 2016 | $400,000 | +2.8% | 31,270 | -67.8% | 0.10% | -23.4% |
| Q1 2016 | $389,000 | -26.2% | 97,250 | +4.0% | 0.12% | -26.2% |
| Q4 2015 | $527,000 | – | 93,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |